GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an...
Pfizer and Moderna could make billions of dollars from COVID-19 booster shots, earnings comparable to the $6 billion generated each year in flu vaccine sales....
In Israel, with 4 million of its near 7 million adults vaccinated, the country is reveling in its reopening, Financial Times (FT) reports. Get the...
The first doses of the Pfizer-BioNTech COVID-19 vaccine, outside of clinical trials, started being administered to healthcare workers and nursing home staffers on Monday (Dec.14)....
Get the Full Story Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required....
Dr. Moncef Slaoui, who acts as President Donald Trump’s COVID-19 vaccine czar, said the U.S. should have enough vaccines to immunize 100 million people by...
As the first approved coronavirus vaccine arrives in the U.K. this week, the next phase of the fight to contain the deadly virus will fall...
With COVID-19’s worldwide case count officially exceeding 11 million and waves of closures sweeping U.S. states in an attempt to stifle the resurgent threat, an...
As other stocks rebounded at the news of a breakthrough in Pfizer and BioNTech’s joint COVID-19 vaccine, bitcoin fell sharply to nearly $14,815, according to...